Abstract 9376: Maximum Dose of N-acetylcysteine and Prevention of Renal Dysfunction in Patients With Chronic Kidney Disease Undergone Surgical Coronary Intervention: A Prospective, Randomized, Double-blind, Controlled Trial

José Jayme Galvão de Lima,Eduesley Santana Santos,Luís Henrique Wolff Gowdak,Fábio Antônio Gaiotto,Luiz Boro Puig,Valeria Costa-Hong,Rodolfo Leite Arantes,Luiz Antonio Machado César,Luiz Aparecido Bortolotto

Abstract 9376: Maximum Dose of N-acetylcysteine and Prevention of Renal Dysfunction in Patients With Chronic Kidney Disease Undergone Surgical Coronary Intervention: A Prospective, Randomized, Double-blind, Controlled Trial

2012

José Jayme Galvão de Lima
Eduesley Santana Santos
Luís Henrique Wolff Gowdak
Fábio Antônio Gaiotto
Luiz Boro Puig
Valeria Costa-Hong
Rodolfo Leite Arantes
Luiz Antonio Machado César
Luiz Aparecido Bortolotto

Background: The role of N-acetylcysteine (NAC) for the prevention of renal damage in experimental models and in diverse clinical settings is controversial. Disparate results may be caused by differ...

Keywords:

Cardiology
Randomized controlled trial
Acetylcysteine
Diabetes mellitus
Internal medicine
Kidney disease
Medicine
Renal function
Kidney
maximum dose
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations